Efficacy of lamotrigine in disabling myoclonus in a patient with an mtDNA A3243G mutation.
Epilepsy Service, Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA. djcostello@partners.org
Daniel J
DJ
Costello
Katherine B
KB
Sims
D000927:Anticonvulsants / Q000627:therapeutic use*; D004272:DNA, Mitochondrial / Q000235:genetics*; D004569:Electroencephalography; D006801:Humans; D000077213:Lamotrigine; D008297:Male; D009154:Mutation / Q000235:genetics* / Q000502:physiology*; D009207:Myoclonus / Q000188:drug therapy* / Q000235:genetics*; D014227:Triazines / Q000627:therapeutic use*; D014815:Vitamins / Q000627:therapeutic use; D055815:Young Adult
D000927:Anticonvulsants; D004272:DNA, Mitochondrial; D014227:Triazines; D014815:Vitamins; D000077213:Lamotrigine